Type 1 Diabetes

Young children newly diagnosed with type 1 diabetes were more likely to use continuous glucose monitoring regularly if they had private insurance, according to findings published in Diabetes Technology & Therapeutics.

The estimated prevalence of type 1 and type 2 diabetes increased significantly among children and adolescents in the U.S. from 2001 to 2017, according to findings published in JAMA.

Children in the United Kingdom presented with more severe diabetic ketoacidosis cases during the first 3 months of the COVID-19 pandemic compared with the preceding 9 months, according to findings published in Diabetic Medicine.

Parent-reported hypoglycemia fear and diabetes-specific family conflict may predict HbA1c trajectories for children aged 5 to 9 years with recent-onset type 1 diabetes, according to findings published in Diabetic Medicine.

Non-Hispanic Black children are less likely to start continuous glucose monitoring within 1 year of diabetes diagnosis compared with non-Hispanic white children, according to study data.

The percentage of youths with type 1 diabetes spending at least 70% time in range more than doubled after 3 months of using a hybrid closed-loop insulin delivery system, according to a study published in Diabetes Technology & Therapeutics.

Children and teens with type 1 diabetes and two or more comorbidities or a mental health condition have a worse health-related quality of life compared with those with no comorbidities, according to a study published in Diabetic Medicine.

The FDA issued a complete response letter for a biologics license application for teplizumab for the delay of type 1 diabetes in high-risk children and adults, stating a study failed to show pharmacokinetic comparability.

Older adults with type 1 diabetes had more time in range and less time below range with closed-loop insulin pump therapy compared with a sensor-augmented pump, according to a presenter.

ADO09, a co-formulation of pramlintide and insulin A21G, was associated with better glucose levels, improved time in range and more weight loss among people with type 1 diabetes compared with insulin aspart, according to a presenter.